Susan Hasty, Publisher
Table of Contents . . . January 23rd, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in TB and Outbreaks Week | Other Publications
Tuberculosis - Clinical Assessment Combined with Laboratory Assays Deliver Better Diagnosis
Antibiotic Resistance - Linezolid Might Help Combat Resistant Bacteria
Education - Tanzanian Clinic Outpatients Display Limited Knowledge of Tuberculosis Facts
Malaria - Researchers Move Closer to Treatment that Stops Infection
Nosocomial Infection - Hospital Patients Get Staph Infections from Their Own Germs
Pulmonary Tuberculosis - Elevated Cortisol Levels in Lungs Offer Possible Explanation for Immunoparesis
Tuberculosis - Fluorescent Microscopy Makes Most of Single Sputum Sample
Tuberculosis - Harlem Fast Track Program Provides Model for Others to Use for Latent TB
Tuberculosis - Public Health Workers Assess TB Risk in Asian Refugees in Australia
Mycobacterial Infections - Actimmune Phase II Trial Initiated to Treat Atypical Disease
Conference Announcement - Antiviral Drug Summit Focuses on Anti-HIV, HBV/HCV, and Influenza
Education - Poor Reading Skills Stop Inmates from Learning Tuberculosis Materials
Hand-Foot-and-Mouth Disease - Virus Identified Following Death of Four-Year-Old Singapore Boy
Immunology - Engineered Mouse Virus Eliminates Cell-Mediated Response
Influenza - Researchers Argue the Case For and Against Vaccination Programs
Lyme Disease - Study Sheds New Light on Disease Transmission, Implications for Vaccine Development
Malaria - Initiative Establishes Partnership to Test Vaccine Candidates
Meningitis - Mass Immunization Effective Among Teens and Young Adults, But Not Very Young Children
Otitis Media - Single Ceftriaxone Dose Can Increase Amount of Penicillin-Resistant Bacteria
Polio - Outbreak in Haiti and the Dominican Republic Under Control
Vaccine Development - HLA-A*0201 Recognizes Epitopes of Mycobacterium tuberculosis Protein Component
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.